Feasibility of bremsstrahlung dosimetry for direct dose estimation in patients undergoing treatment with 90Y-ibritumomab tiuxetan

被引：0
|
作者：
C. Arrichiello
L. Aloj
M. Mormile
L. D’Ambrosio
F. Frigeri
C. Caracò
M. Arcamone
F. De Martinis
A. Pinto
S. Lastoria
机构：
[1] Istituto Nazionale per lo Studio e la Cura dei Tumori,Nuclear Medicine Department
[2] Fondazione “G. Pascale”,Hematology
[3] Istituto Nazionale per lo Studio e la Cura dei Tumori,Oncology and Stem Cells Transplantation Unit, Department of Hematology
[4] Fondazione “G. Pascale”,IRCCS
[5] Istituto Nazionale per lo Studio e la Cura dei Tumori,undefined
[6] Fondazione “G. Pascale”,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词：
Radioimmunotherapy; Ibritumomab tiuxetan; Non-Hodgkin’s lymphoma; Dosimetry; Bremsstrahlung imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：956 / 966
页数：10
相关论文
共 50 条
  • [31] EFFICACY OF 90Y-IBRITUMOMAB TIUXETAN IN EXTRANODAL MARGINAL-ZONE LYMPHOMA (EMZL)
    Vanazzi, A.
    Grana, C.
    Pruneri, G.
    Crosta, C.
    Papi, S.
    Pinto, A.
    Paganelli, G.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 315 - 315
  • [32] 90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma
    Hoffmann, Martha
    Troch, Marlene
    Eidherr, Harald
    Traub-Weidinger, Tatjana
    Jonak, Constanze
    Muellauer, Leonhard
    Raderer, Markus
    LEUKEMIA & LYMPHOMA, 2011, 52 (01) : 42 - 45
  • [33] Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice
    Jacene, Heather A.
    Filice, Ross
    Kasecamp, Wayne
    Wahl, Richard L.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (11) : 1767 - 1776
  • [34] Red Marrow Dosimetry and Stem Cell Reinfusion in High Dose 90Y - Ibritumomab Tiuxetan
    Vanazzi, Anna
    Laszlo, Daniele
    Cremonesi, Marta
    Grana, Chiara Maria
    Papi, Stefano
    Alietti, Alessandra
    Liptrott, Sarah Jayne
    Calabrese, Liliana
    Paganelli, Giovanni
    Martinelli, Giovanni
    BLOOD, 2008, 112 (11) : 763 - 763
  • [35] Radioimmunotherapy with 90Y-Zevalin (90y-Ibritumomab Tiuxetan) in Patients with Non Hodgkin Lymphoma: Preliminary Experience of our Centre
    Vallejos, V.
    Calvo, E.
    Xicoy, B.
    Riba, J.
    Rubio, A.
    Sola, M.
    Mila, M.
    Rosado, M.
    Ribera, J. M.
    Fraile, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S352 - S353
  • [36] 90Y-ibritumomab tiuxetan:: Rationale for patient selection in the treatment of indolent non-Hodgkin's lymphoma
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 2005, 32 (01) : S44 - S49
  • [37] Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET
    Saiyada N. F. Rizvi
    Otto J. Visser
    Maria J. W. D. Vosjan
    Arthur van Lingen
    Otto S. Hoekstra
    Josée M. Zijlstra
    Peter C. Huijgens
    Guus A. M. S. van Dongen
    Mark Lubberink
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 512 - 520
  • [38] Initial experience with rituximab and 90Y-ibritumomab tiuxetan for the treatment of mature B-cell lymphoma.
    Al-Shemmari, Salem H.
    Al-Mohannadi, Shihab M.
    Khan, Haider A.
    Sajnani, Kamlesh P.
    BLOOD, 2006, 108 (11) : 266B - 267B
  • [39] Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET
    Rizvi, Saiyada N. F.
    Visser, Otto J.
    Vosjan, Maria J. W. D.
    van Lingen, Arthur
    Hoekstra, Otto S.
    Zijlstra, Josee M.
    Huijgens, Peter C.
    van Dongen, Guus A. M. S.
    Lubberink, Mark
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (03) : 512 - 520
  • [40] Consolidation of chemotherapy response in mantle cell lymphoma (MCL) patients with 90Y-ibritumomab tiuxetan (90Y-Zevalin) radioimmunotherapy (RIT).
    Jurczak, W
    Giza, A
    Krochmalczyk, D
    Wegrzyn, J
    Hubalewska-Dydejczyk, A
    Sowa-Staszczak, A
    Knopinska-Posluszny, W
    Zdziarska, B
    Kyrcz-Krzemien, S
    Boguradzki, P
    Poplawska, L
    Skotnicki, A
    BLOOD, 2005, 106 (11) : 690A - 690A
12345